Alteration of the fecal microbiome in patients with cholecystectomy: potential relationship with postcholecystectomy diarrhea - before and after study.
Journal
International journal of surgery (London, England)
ISSN: 1743-9159
Titre abrégé: Int J Surg
Pays: United States
ID NLM: 101228232
Informations de publication
Date de publication:
01 Sep 2023
01 Sep 2023
Historique:
received:
30
01
2023
accepted:
14
05
2023
medline:
23
10
2023
pubmed:
8
6
2023
entrez:
8
6
2023
Statut:
epublish
Résumé
Bile acid (BA) is a crucial determinant of the gut microbiome, and cholecystectomy can alter the physiology of BA. Physiological changes in BA resulting from cholecystectomy can also influence the gut microbiome. We aimed to identify the specific taxa associated with perioperative symptoms, including postcholecystectomy diarrhea (PCD), and to evaluate the effect of cholecystectomy on the microbiome by investigating the fecal microbiome of patients with gallstones. We analyzed the fecal samples of 39 patients with gallstones (GS group) and 26 healthy controls (HC group) to evaluate their gut microbiome. We also collected fecal samples from GS group 3 months postcholecystectomy. Symptoms of patients were evaluated before and after cholecystectomy. Further, 16S ribosomal RNA amplification and sequencing were performed to determine the metagenomic profile of fecal samples. The microbiome composition of GS differed from that of HC; however, the alpha diversity was not different. No significant microbiome alterations were observed before and after cholecystectomy. Moreover, GS group showed a significantly lower Firmicutes to Bacteroidetes ratio before and after cholecystectomy than the HC group (6.2, P< 0.05). The inter-microbiome relationship was lower in GS than in HC and tended to recover 3 months after surgery. Furthermore, ~28.1% ( n =9) of patients developed PCD after surgery. The most prominent species among PCD (+) patients was Phocaeicola vulgatus. Compared with the preoperative state, Sutterellaceae , Phocaeicola , and Bacteroidals were the most dominant taxa among PCD (+) patients. GS group showed a different microbiome from that of HC; however, their microbiomes were not different 3 months after cholecystectomy. Our data revealed taxa-associated PCD, highlighting the possibility of symptom relief by restoring the gut microbiome.
Sections du résumé
BACKGROUND
BACKGROUND
Bile acid (BA) is a crucial determinant of the gut microbiome, and cholecystectomy can alter the physiology of BA. Physiological changes in BA resulting from cholecystectomy can also influence the gut microbiome. We aimed to identify the specific taxa associated with perioperative symptoms, including postcholecystectomy diarrhea (PCD), and to evaluate the effect of cholecystectomy on the microbiome by investigating the fecal microbiome of patients with gallstones.
METHODS
METHODS
We analyzed the fecal samples of 39 patients with gallstones (GS group) and 26 healthy controls (HC group) to evaluate their gut microbiome. We also collected fecal samples from GS group 3 months postcholecystectomy. Symptoms of patients were evaluated before and after cholecystectomy. Further, 16S ribosomal RNA amplification and sequencing were performed to determine the metagenomic profile of fecal samples.
RESULTS
RESULTS
The microbiome composition of GS differed from that of HC; however, the alpha diversity was not different. No significant microbiome alterations were observed before and after cholecystectomy. Moreover, GS group showed a significantly lower Firmicutes to Bacteroidetes ratio before and after cholecystectomy than the HC group (6.2, P< 0.05). The inter-microbiome relationship was lower in GS than in HC and tended to recover 3 months after surgery. Furthermore, ~28.1% ( n =9) of patients developed PCD after surgery. The most prominent species among PCD (+) patients was Phocaeicola vulgatus. Compared with the preoperative state, Sutterellaceae , Phocaeicola , and Bacteroidals were the most dominant taxa among PCD (+) patients.
CONCLUSION
CONCLUSIONS
GS group showed a different microbiome from that of HC; however, their microbiomes were not different 3 months after cholecystectomy. Our data revealed taxa-associated PCD, highlighting the possibility of symptom relief by restoring the gut microbiome.
Identifiants
pubmed: 37288587
doi: 10.1097/JS9.0000000000000518
pii: 01279778-990000000-00408
pmc: PMC10498850
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2585-2597Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Références
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology 2009;136:1134–1144.
Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 2005;7:132–140.
Housset C, Chretien Y, Debray D, et al. Functions of the gallbladder. Compr Physiol 2016;6:1549–1577.
Ridlon JM, Kang DJ, Hylemon PB, et al. Bile acids and the gut microbiome. Curr Opin Gastroenterol 2014;30:332–338.
Keren N, Konikoff FM, Paitan Y, et al. Interactions between the intestinal microbiota and bile acids in gallstones patients. Environ Microbiol Rep 2015;7:874–880.
Yoon WJ, Kim HN, Park E, et al. The impact of cholecystectomy on the gut microbiota: a case–control study. J Clin Med 2019;8:79.
Sauter GH, Moussavian AC, Meyer G, et al. Bowel habits and bile acid malabsorption in the months after cholecystectomy. Am J Gastroenterol 2002;97:1732–1735.
Xu Y, Wang J, Wu X, et al. Gut microbiota alteration after cholecystectomy contributes to post-cholecystectomy diarrhea via bile acids stimulating colonic serotonin. Gut Microbes 2023;15:2168101.
Wanjura V, Sandblom G. How do quality-of-life and gastrointestinal symptoms differ between post-cholecystectomy patients and the background population? World J Surg 2016;40:81–88.
Barrasa JI, Olmo N, Lizarbe MA, et al. Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol In Vitro 2013;27:964–977.
Midtvedt T. Microbial bile acid transformation. Am J Clin Nutr 1974;27:1341–1347.
Tanaka H, Doesburg K, Iwasaki T, et al. Screening of lactic acid bacteria for bile salt hydrolase activity. J Dairy Sci 1999;82:2530–2535.
Fisher M, Spilias DC, Tong LK. Diarrhoea after laparoscopic cholecystectomy: incidence and main determinants. ANZ J Surg 2008;78:482–486.
Li YD, Liu BN, Zhao SH, et al. Changes in gut microbiota composition and diversity associated with post-cholecystectomy diarrhea. World J Gastroenterol 2021;27:391–403.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007;147:573–577.
Mathew G, Agha R, Albrecht J, et al. STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case–control studies in surgery. Int J Surg 2021;96:106165.
Cardona S, Eck A, Cassellas M, et al. Storage conditions of intestinal microbiota matter in metagenomic analysis. BMC Microbiol 2012;12:158.
Tedjo DI, Jonkers DM, Savelkoul PH, et al. The effect of sampling and storage on the fecal microbiota composition in healthy and diseased subjects. PLoS One 2015;10:e0126685.
Chung SC, Leung JW, Li AK. Bile duct size after cholecystectomy: an endoscopic retrograde cholangiopancreatographic study. Br J Surg 1990;77:534–535.
Park SM, Kim WS, Bae IH, et al. Common bile duct dilatation after cholecystectomy: a one-year prospective study. J Korean Surg Soc 2012;83:97–101.
Cotton PB, Elta GH, Carter CR, et al. Gallbladder and sphincter of Oddi disorders. Gastroenterology 2016;150:1420–1429.e2.
Guzior DV, Quinn RA. Review: microbial transformations of human bile acids. Microbiome 2021;9:140.
Cai JS, Chen JH. The mechanism of enterohepatic circulation in the formation of gallstone disease. J Membr Biol 2014;247:1067–1082.
Farina A, Dumonceau JM, Lescuyer P. Proteomic analysis of human bile and potential applications for cancer diagnosis. Expert Rev Proteomics 2009;6:285–301.
Xu Y, Jing H, Wang J, et al. Disordered gut microbiota correlates with altered fecal bile acid metabolism and post-cholecystectomy diarrhea. Front Microbiol 2022;13:800604.
Grigor’eva IN, Romanova TI. Gallstone disease and microbiome. Microorganisms 2020;8:835.
Wahlstrom A, Sayin SI, Marschall HU, et al. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab 2016;24:41–50.
Tian Y, Gui W, Koo I, et al. The microbiome modulating activity of bile acids. Gut Microbes 2020;11:979–996.
Wu T, Zhang Z, Liu B, et al. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genomics 2013;14:669.
Georgescu D, Ionita I, Lascu A, et al. Gallstone disease and bacterial metabolic performance of gut microbiota in middle-aged and older patients. Int J Gen Med 2022;15:5513–5531.
European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol 2016;65:146–181.
Ren X, Xu J, Zhang Y, et al. Bacterial alterations in post-cholecystectomy patients are associated with colorectal cancer. Front Oncol 2020;10:1418.
Hepner GW, Hofmann AF, Malagelada JR, et al. Increased bacterial degradation of bile acids in cholecystectomized patients. Gastroenterology 1974;66:556–564.
Sarashina-Kida H, Negishi H, Nishio J, et al. Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis. Proc Natl Acad Sci U S A 2017;114:10178–10183.
Grigor’eva I, Romanova T, Naumova N, et al. Gut microbiome in a Russian cohort of pre- and post-cholecystectomy female patients. J Pers Med 2021;11:294.
Jaunoo SS, Mohandas S, Almond LM. Postcholecystectomy syndrome (PCS). Int J Surg 2010;8:15–17.
Farrugia A, Attard JA, Hanmer S, et al. Rates of bile acid diarrhoea after cholecystectomy: a multicentre audit. World J Surg 2021;45:2447–2453.
Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003;72:137–174.
Jones ML, Martoni CJ, Ganopolsky JG, et al. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. Expert Opin Biol Ther 2014;14:467–482.
Lee SM, Kim N, Yoon H, et al. Compositional and functional changes in the gut microbiota in irritable bowel syndrome patients. Gut Liver 2021;15:253–261.
Dior M, Delagreverie H, Duboc H, et al. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome. Neurogastroenterol Motil 2016;28:1330–1340.
Hofer U. Microbiome: pro-inflammatory Prevotella ? Nat Rev Microbiol 2014;12:5.
Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology 2017;151:363–374.
Jousimies-Somer HR. Update on the taxonomy and the clinical and laboratory characteristics of pigmented anaerobic gram-negative rods. Clin Infect Dis 1995;20(Suppl 2):S187–S191.
Salyers AA. Bacteroides of the human lower intestinal tract. Annu Rev Microbiol 1984;38:293–313.
Friedrich V, Forné I, Matzek D, et al. Helicobacter hepaticus is required for immune targeting of bacterial heat shock protein 60 and fatal colitis in mice. Gut Microbes 2021;13:1–20.
Luck R, Deppenmeier U. Genetic tools for the redirection of the central carbon flow towards the production of lactate in the human gut bacterium Phocaeicola (Bacteroides) vulgatus . Appl Microbiol Biotechnol 2022;106:1211–1225.
Evans JC, McEneany VL, Coyne MJ, et al. A proteolytically activated antimicrobial toxin encoded on a mobile plasmid of Bacteroidales induces a protective response. Nat Commun 2022;13:4258.
Waidmann M, Bechtold O, Frick JS, et al. Bacteroides vulgatus protects against Escherichia coli -induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 2003;125:162–177.
Yoshida N, Emoto T, Yamashita T, et al. Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation 2018;138:2486–2498.
Chen YJ, Wu H, Wu SD, et al. Parasutterella, in association with irritable bowel syndrome and intestinal chronic inflammation. J Gastroenterol Hepatol 2018;33:1844–1852.
Wolter M, Grant ET, Boudaud M, et al. Leveraging diet to engineer the gut microbiome. Nat Rev Gastroenterol Hepatol 2021;18:885–902.
John GK, Mullin GE. The Gut microbiome and obesity. Curr Oncol Rep 2016;18:45.
Sanmiguel C, Gupta A, Mayer EA. Gut microbiome and obesity: a plausible explanation for obesity. Curr Obes Rep 2015;4:250–261.